Sponsors (25)
The bill increases regulatory oversight and public disclosure of fracking chemicals and provides emergency medical access to proprietary identities, but it preserves trade-secret protections and creates potential delays and compliance costs that limit full transparency and could raise energy costs.
State and EPA regulators (who obtain primacy) can now treat hydraulic fracturing injections as underground injection, closing a regulatory gap and enabling UIC oversight and enforcement.
Residents near fracking sites (rural communities and homeowners) will gain public access to chemicals used before and after fracturing through posted disclosures, improving local awareness of water and air risks and supporting community monitoring and research.
Treating medical personnel and hospitals will be able to obtain proprietary chemical identities immediately during declared medical emergencies, enabling more informed and prompt care for exposed patients.
Residents and the public will still face incomplete transparency because the bill preserves trade-secret protections that prevent full public disclosure of proprietary formulas and thus limit complete understanding of risks.
Hospitals and exposed patients may experience delays or uncertainty in receiving full chemical information because emergency disclosures depend on operator cooperation, confidentiality agreements, and state/EPA determinations of a 'medical emergency'.
Energy operators will face higher compliance costs to disclose proprietary chemical lists and publicly post non-proprietary details, which could translate into higher energy prices or reduced investment and jobs in the sector.
Based on analysis of 2 sections of legislative text.
Classifies hydraulic fracturing injections as underground injection under UIC and requires pre/post chemical disclosures with public posting and emergency access to trade‑secret identities for medical care.
Introduced November 18, 2025 by Diana DeGette · Last progress November 18, 2025
Makes hydraulic fracturing injections for oil, gas, or geothermal production subject to the federal Underground Injection Control program and requires operators to disclose the chemicals used. States (or EPA when it has primacy) must require pre‑fracturing and within‑30‑day post‑fracturing lists of chemicals (including constituents, CAS numbers, MSDS when available, and volumes) and post those disclosures publicly; proprietary formulas remain protected but proprietary identities must be disclosed immediately to regulators or treating medical personnel in a medical emergency, with confidentiality safeguards.